We are live on ! Find out more
NSPRZ

InspireMD, Inc. Series B Warrants

Delisted

NSPRZ was delisted on the 14th of March, 2022.

3 hedge funds and large institutions have $162K invested in InspireMD, Inc. Series B Warrants in 2017 Q2 according to their latest regulatory filings, with 3 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
3
Holders Change
+3
Holders Change %
% of All Funds
0.07%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change
Change in
Stake
SM
1
Sabby Management
Florida
$155K +$262K +2,002,348 New
Susquehanna International Group
2
Susquehanna International Group
Pennsylvania
$7K +$12.2K +93,748 New
VKH
3
Virtu KCG Holdings
New York
+$7.02K +53,748 New

NSPRZ Hedge Fund Activity: Q2 2017 in Review

3 of the 4,012 institutional investors tracked by Wall St. Rank reported a position in InspireMD, Inc. Series B Warrants (NSPRZ) for Q2 2017, worth a combined $162K.

Buyers outnumbered sellers: 3 funds opened new NSPRZ positions and 0 closed out — a net gain of 3 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Sabby Management, opening a new position worth an estimated $262K.

  • 3 institutional investors held InspireMD, Inc. Series B Warrants (NSPRZ) as of Q2 2017, up from 0 in Q1 2017.
  • Funds reported $162K of InspireMD, Inc. Series B Warrants stock for Q2 2017.
  • 3 funds opened new InspireMD, Inc. Series B Warrants positions in Q2 2017 and 0 closed out, a net change of +3 holders.
  • The largest InspireMD, Inc. Series B Warrants buyer in Q2 2017 was Sabby Management, an estimated $262K added.

Based on aggregated 13F filings for Q2 2017.